Data will help scientists worldwide design better experiments.
University Cancer Research Fund updates, record poster session highlights of 2011 scientific retreat
The sixth annual UNC Lineberger scientific retreat drew a record number of posters – 68 – for the poster session and competition – and close to 150 people for the talks and reception.
Chapel Hill - Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th Public Library of Science.
Tom May used to donate blood, but not often. If he had it to do over, he’d give as much as possible. But he can’t.
CHAPEL HILL, N.C. – Carol Otey, PhD talks about the hope & health that has resulted from recent pancreatic research & collaboration on the May 14, 2011 broadcast of Here's to Your Health.
Chapel Hill - When cancer patients experience medical problems, they may visit emergency departments, but how often and for what reasons, there is little data.
A University of North Carolina at Chapel Hill study has joined the ranks of an elite group of programs recognized for their contributions to reducing cancer.
Innovative collaboration between physics and cell biology demonstrates pathway
CHAPEL HILL, N.C. – Dr. Carolyn Sartor discussed the “New Life After Cancer” organization on the April 28, 2011 broadcast of Here's to Your Health. Dr. Sartor is a breast cancer survivor and former Chair of Radiation Oncology at UNC.
Richard Goldberg, MD, distinguished professor and chief of the division of hematology/oncology, has been appointed to chair the 2012 Gastrointestinal Cancers Symposium Steering Committee on behalf of the American Society for Clinical Oncology (ASCO).
The 35th annual UNC Lineberger scientific symposium attracted more than 530 participants. Held at the Friday Center on April 27-28, 2011, the event featured speakers on "Cell Metabolism and Cancer."
NCCU-UNC Lineberger scientific collaboration yields new findings
Prestigious Executive Leadership in Academic Medicine Program builds pipeline of women leaders
CHAPEL HILL – Researchers at the University of North Carolina at Chapel Hill School of Medicine, after isolating normal stem cells that form the developing placenta, have given them the same properties of stem cells associated with an aggressive type of breast cancer.
Chapel Hill, NC - Samuel Cykert, MD, has received a $1.8 million five-year grant from the American Cancer Society (ACS) to study “Lung Cancer Surgery: Decisions Against Life Saving Care.”
The UNC-Mission Hospital Cancer Partnership, part of the UNC Cancer Network, welcomes Candace Cox, RN, OCN, to the program staff.
Local show features UNC Lineberger
A study of DNA rearrangements in roundworm chromosomes may offer new insight into large-scale genome duplications that occur in developing tumors.
UNC physician scientist receives National Academy of Sciences grant to develop cancer nanotechnology
New research from the University of North Carolina at Chapel Hill School of Medicine adds clarity to the connection. The study published on-line April 10th in the journal Nature Immunology finds that saturated fatty acids but not the unsaturated type can activate immune cells to produce an inflammatory protein, called interleukin-1beta.
"Tet is likely to be one of the important players for stem cell reprogramming."
Prestigious Breast Cancer Research Foundation-AACR Grant funds preclinical studies
CHAPEL HILL, N.C. - On Friday, March 11, a group of nurses gathered for a UNC Health Care Grand Rounds presentation by Jerome Schiro, RN, MN, OCN, Pat Decator, RN, BSN, OCN, and Amy De Pue, RN, BS, OCN.
UNC researchers working toward a rehabilitation road map
CHAPEL HILL, N.C. - My Colon Cancer Coach, a new website that launched this week, serves as a tool to help people diagnosed with colon cancer.
CHAPEL HILL, N.C. - The article "Next Generation Treatment for Triple-Negative and Basal-Cell Breast Cancer" written by Jonathan Batchelor and published on the website cancernetwork.com on March 9, 2011 features an interview with UNC Lineberger member Lisa Carey, MD.
CHAPEL HILL, N.C. - A UNC study released this week in the Journal of Clinical Oncology finds an increasing incidence of squamous cell carcinoma of the oral tongue in young white females in the United States over the last three decades.
C.A.R.E. Behind the Chair® program scheduled for May9
CHAPEL HILL, N.C. - Federico Innocenti, MD, PhD, has been appointed associate professor of pharmacy in the UNC Eshelman School of Pharmacy. He will serve as associate director of the UNC Institute for Pharmacogenomics and Individualized Therapy and a member of UNC Lineberger Comprehensive Cancer Center.
CHAPEL HILL, N.C. - A Triangle-based UNC spinoff company at the forefront of efforts to use nanotechnology to tackle diseases has received a $10 million investment from the Bill & Melinda Gates Foundation.
UNC Lineberger Physician Co-Author of Study of Screening Mammography in Women with Personal History of Breast Cancer
James P. Evans, MD, PhD is lead author of a commentary about the potential of genomic medicine.
Weili Lin, PhD, has been appointed Director of the UNC Biomedical Research Imaging Center (BRIC).
UNC Lineberger member Kurt Ribisl, PhD, was part of the study's research team.
Sixty physicians at the University of North Carolina Hospitals are listed in the latest version of “America’s Top Doctors,” a compilation that is published annually by Castle Connolly Medical Ltd. Of those, 32 are members of UNC Lineberger Comprehensive Cancer Center or involved in UNC Cancer Care’s multidisciplinary programs.
Richard Goldberg, MD is physician-in-chief of the N.C. Cancer Hospital and UNC Lineberger associate director of clinical research.
When the U.S. Food and Drug Administration (FDA) proposed new rules restricting outdoor tobacco advertising near schools and playgrounds in 2009, the tobacco industry argued that such rules would lead to a near complete ban on tobacco advertising in urban areas. An article in the March 2011 issue of the American Journal of Preventive Medicine shows that the effect of these rules would be less severe on businesses than the industry contends.
The article discusses Bernard’s work with the UNC Palliative Care Program and the Supportive Care Consult Service and Clinic.
Anders was chosen for her work on breast cancer brain metastases. Hoadley was selected for her contributions to the analysis of glioblastomas.
The Henry family shares the story of brothers Collin and Patrick, both diagnosed with cancer and receiving care at the N.C. Cancer Hospital.
UNC Lineberger members are involved in over 20 active startups.
It's a gene called DOT1L, and if you don't have enough of the DOT1L enzyme, you could be at risk for some types of heart disease.
Interested in starting a regular exercise program and supporting a good cause?
University Cancer Research Fund Enables Innovative Solutions to Complex Problems
Kaposi sarcoma-associated herpesvirus produces a protein that blocks the cell's inflammatory response
C. elegans model shows how RAS oncogene switching determines a cell's fate
Researchers investigating a genetic mutation in brain cancer and leukemia patients have discovered how one cancer metabolite battles another normal metabolite to contribute cancer development. Helping the “good guys” win that battle could yield new approaches for treatment.
Heartfelt thanks to the staff of the N.C. Cancer Hospital, fellow UNC employees, our volunteers, patients, families, and friends. The Oncology Winter Coat Drive was a tremendous success - 107 winter coats were collected and distributed to our families and their caregivers throughout the month of January until February 11, 2011. Hats, scarves, gloves, and socks were added to each winter coat selection as needed. A very special Valentine’s Day thank you to all for sharing your hearts!
An Interview With Oncology Clinical Pharmacist John Valgus, PharmD, BCOP, CPP
UNC Lineberger Primary Benefactor for the Wachovia Tar Heel 10 Miler - Chapel Hill's Largest Running Event
Technology developed by UNC Lineberger members may lead to diagnostic test
Resulting Database to Yield Big Gains for Genetic Scientists
Normal humans produce a novel, circular form of non-coding RNA that regulates aging
UNC Hospitals is one of 378 facilities in the world, and among only 6 percent of all U.S. hospitals, that have earned Magnet designation.
Organization will receive The Artist in Residence Program to help people affected by cancer
G-Zero Therapeutics funded under Qualifying Therapeutic Discovery Project
In a study published this month in the Journal of Clinical Oncology, the results of a clinical trial of the drug bevacizumab to treat colon cancer in combination with the standard therapy found that the drug did not significantly increase disease-free survival in patients with stage II and stage III colon cancer.
Cell signaling protein may hold key to blocking long-studied genetic mutation
$11.9 Million in awards to address cancer disparities
N.C. native John Isner and doubles partner Sam Querrey to host
ABC Anchor Robin Roberts Guest of Honor at Kickoff Event
Project Focuses on Efficient, Low-Cost Genetic Analysis
UNC Scientists Receive Grant to Develop Nanotechnology for Pancreatic Cancer Diagnosis and Treatment
National Cancer Institute awards $13.6 million to UNC's Carolina Center of Cancer Nanotechnology Excellence
The article "How Old Are You, Really?" written by Mark Derewicz and published in the Fall 2010 issue of Endeavors magazine features UNC Lineberger member Ned Sharpless, MD. Dr. Sharpless is an associate professor of medicine and genetics and associate director for translational research at UNC Lineberger.
Part of UNC Comprehensive Cancer Support Program
UNC Lineberger team will examine minority, underserved populations
Hearing of the House Energy and Commerce Committee's Subcommittee on Oversight and Investigations, July 20, 2010
UNC researchers reveal how a protein called Tet1 helps stem cells keep their “stemness” in a paper published in Nature.
UNC's Goldberg a Key Contributor
This news story was originally published on June 17, 2010 by Campbell University. Reprinted with permission
Nancy Thomas, MD, PhD, Co-Director of UNC’s Interdisciplinary Melanoma Program, talks about sun safety and early detection of skin cancer
Evans is director of clinical cancer genetics at UNC Lineberger. Article originally published in the June 27, 2010 issue of Newsday.
Discovery has potential for cancer patients and disaster victims
Strategic Partnership to Advance Nanotechnology-Based Diagnosis and Treatment
UNC Lineberger Genetics Policy, Law, Medicine Expert Discusses March 29, 2010 US District Court Gene Patenting Ruling
Group Received ASCO 2010 Clinical Trial Participation Award
James Bear PhD, and Klaus Hahn, PhD, Directors
UNC-developed technique has broad applications in cancer, biomedical research
Program brings top cancer expertise to the Outer Banks
Local Group Bikes Across the Country to Raise Money for UNC Lineberger
Jean and Woody Durham Honored with Service Award from UNC Lineberger Comprehensive Cancer Center in Chapel Hill
Findings may illuminate how cancer forms and migrates
Findings have potential for cancer, other age-related diseases
QUANTEC review replaces 20-year old guidelines
This profile is part of a series highlighting how UNC Lineberger and the UNC School of Medicine are shaping the next generation of cancer researchers and physicians
Join the National Marrow Donor Program’s registry and you could save a life!
Study from The Cancer Genome Atlas an important step towards personalized therapy
Jean Sellers, RN, MSN, OCN, Talks about Helping Patients Cope Financially in the Latest Issue of ONS Connect
UNC Lineberger Comprehensive Cancer Center a Beneficiary
National effort will shape the future of cancer research and treatment
Chapel Hill, NC - A disagreement between Nancy Allbritton, MD, PhD and David Lawrence, PhD over which cancer - breast or prostate - should be the higher priority in their partnership resulted in two successful NIH grant proposals. Lawrence is taking the lead on a prostate cancer grant while Allbritton leads a breast cancer grant – totaling almost $5 million over the next five years.
Chapel Hill, NC - Hyman B. Muss, MD, has joined the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill School of Medicine. Muss will be a professor of medicine and will develop and lead a new program in geriatric oncology.
Members of the NC General Assembly are touring the North Carolina Cancer Hospital to get an early view of the state’s new state-of-the-art facility. Greeted by UNC-Chapel Hill Chancellor Holden Thorp and UNC School of Medicine Dean Bill Roper, the legislators visited several key locales in the building that will improve the way cancer care is delivered at UNC and across North Carolina
CHAPEL HILL –Dr. Shelley Earp, UNC Lineberger director, was invited to address the NC Senate Science and Technology Committee to talk about UNC and the Lineberger Comprehensive Cancer Center as the state’s Center of Excellence in Cancer Research.